Top Markets
#1 Bitcoin TRC20 Bitcoin TRC20 +11.31%
#2 Seeker Seeker +8.57%
#3 Cash Cat Cash Cat +6.38%
#4 龙虾 (Lobster) 龙虾 (Lobster) +6.01%
#5 Pons Pons +5.82%
#6 Arbitrum Arbitrum +5.71%
#7 Siacoin Siacoin +5.70%
#8 Story Story +5.50%
#9 Pump.fun Pump.fun +5.01%
#10 Unit Pump Unit Pump +5.01%
Coin of the day
Bitcoin TRC20 Bitcoin TRC20
Instellingen
Taal
DUTCH
Valuta
USD
Thema
EirGenix Inc. EirGenix Inc.

EirGenix Inc.

6589
Rang in aandelen #14111
EirGenix Inc., founded in 2012 and based in New Taipei City, Taiwan, functions... EirGenix Inc., founded in 2012 and based in New Taipei City, Taiwan, functions as a contract development and manufacturing organization (CDMO) with operations spanning both domestic and international markets. The company offers a comprehensive range of services, encompassing cell line creation, process optimization, analytical testing and quality control, and current Good Manufacturing Practice (cGMP) compliant production utilizing both mammalian and microbial expression systems. They also specialize in services related to antibody-drug conjugates (ADCs). Beyond its service offerings, EirGenix is actively engaged in developing several therapeutic candidates. This pipeline includes EG12014/EGI014, a Trastuzumab biosimilar intended for cancer therapy, which has reached the biologics license application (BLA) submission stage. Other oncology-focused developments are EG1206A, a Pertuzumab biosimilar currently in Phase I clinical trials; EG13074, in preclinical development; and TSY0110(EG12043), an antibody-drug conjugate also in preclinical stages. Additionally, the company is advancing EG12021, a Bevacizumab biosimilar for cancer treatment, and EG62054, another biosimilar, both in preclinical development. In addition to its core activities, EirGenix manufactures and distributes a rapid antigen test for COVID-19, as well as the CRM197 carrier protein under the designation EG74032.
Aandeelprijs
$1.46
Laatst gesynchroniseerd: 2026-07-28
Marktkapitalisatie
$435.25M
Verandering (1 dag)
-2.34%
Verandering (1 jaar)
-25.65%
Land
TW
Handel EirGenix Inc. (6589)

Categorie

Healthcare
Koersgeschiedenis voor EirGenix Inc. (6589)
Hoogste slotkoers: $1.51 op 2026-07-01

Laagste slotkoers: $1.20 op 2016-11-01
Koersgeschiedenis van EirGenix Inc. van 2016 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -13.78%
2025 -9.30%
2024 -26.56%
2023 -26.09%
2022 8.79%
2021 147.12%
2020 94.40%
2019 -9.39%
2018 16.53%
2017 -30.22%
2016 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $544.38 39.22%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 45.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.88 -10.84%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.80 476.17%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $749.90 5.10%
CH